Regulatory

Clinical trials have long been criticized for their lack of diversity, particularly in the participation of women. Historically, such exclusions have led to significant gaps in medical knowledge and treatment efficacy across genders, resulting in potentially biased outcomes for a substantial

As the Biden administration prepared to leave office, it enacted a significant order titled "HIPAA Security Rule to Strengthen the Cybersecurity of Electronic Protected Health Information." This order could potentially destabilize the healthcare sector's financial and operational

In 2025, Federally Qualified Health Centers (FQHCs) and Community Health Centers (CHCs) across the United States will undergo transformative regulatory changes. These changes will impact data reporting, preventive services billing, and care management billing, necessitating comprehensive

The oversight practices of the Food and Drug Administration (FDA) regarding food additives and substances have come under scrutiny. This article explores the FDA's regulation of food safety, the autonomy granted to food companies, and the health risks associated with certain ingredients,

Imagine unlocking a code that holds the secret to the myriad complexities of brain evolution and the onset of neurological diseases. This concept has come closer to reality with a pivotal study led by a Belgian research team, which delves deep into the genetic regulatory codes that control brain

Boehringer Ingelheim has made significant strides in their research on progressive pulmonary fibrosis (PPF) with the successful results of their Phase III FIBRONEER™-ILD trial. This trial marks a critical milestone for Nerandomilast, an investigational oral preferential inhibitor of p